|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3317301 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16757391.4 |
| Date of filing the European patent application | 2016-07-28 | |
| (97) | Date of publication of the European application | 2018-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-07 |
| (46) | Date of publication of the claims translation | 2021-07-26 |
| (86) | Number | PCT/US2016/044545 |
| Date | 2016-07-28 |
| (87) | Number | WO 2017/019894 |
| Date | 2017-02-02 |
| (30) | Number | Date | Country code |
| 201562198492 P | 2015-07-29 | US |
| (72) |
DRANOFF, Glenn, US
TRIEBEL, Frédéric, FR
BRIGNONE, Chrystlle, FR
BLATTLER, Walter, A., US
MATARAZA, Jennifer, Marie, US
SABATOS-PEYTON, Catherine, Anne, US
CHANG, Hwai, Wen, US
GERHARD, Johann, US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
Immutep S.A.S. , 21 Rue Jean Rostand, 91893 Orsay Cedex, FR |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kombinuotos terapijos, apimančios antikūno molekules prieš LAG-3 |
| COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3 |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 10 | 231.00 EUR |
| 2026-07-28 |